Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IPSC
#3009
Century Therapeutics, Inc. Common Stock
2.3
2
+6.42%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+6.42%
Monthly Change
-13.43%
6 month change
+346.15%
Cambio anual
+256.92%
Cierres anteriores
2.1
8
Open
2.3
2
Bid
Ask
Low
2.3
2
High
2.3
2
Volumen
15
Markets
Acciones
Atención Sanitaria
IPSC
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
58.82 M
59.17 M
64.82 M
86.05 M
—
Valuation ratios
Enterprise value
876.43 M
209.81 M
188.61 M
28.46 M
-3.04 M
Price to earnings ratio
-5.36
-2.19
-1.6
-0.63
-6.12
Price to sales ratio
—
55.21
94.06
12.06
13.21
Price to cash flow ratio
-5.77
20.43
-2.38
-0.72
-1.82
Price to book ratio
1.3
0.95
1.14
0.49
0.65
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.22
0.27
0.38
0.36
0.6
Return on equity %
0.24
0.43
0.74
0.78
0.89
Return on invested capital %
179.14
271.7
318.66
240.44
419.32
Gross margin %
—
100
100
100
—
Operating margin %
—
2 574.17
6 556.87
2 096.48
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
2 518.41
6 115.12
1 920.87
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
14.57
10.72
9.92
1.5
30.16
Inventory turnover
—
—
—
—
—
Asset turnover
—
0.01
0.01
0.02
0.34
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0.02
0.01
0.01
—
—
Long term debt to total equity ratio
0.02
0.01
0.02
—
—
Per share metrics
Operating cash flow per share
2.75
0.24
1.53
1.4
1.33
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
6.88
5.46
2.99
2.41
7.67
Net current asset value per share
7.04
5.54
3.06
2.47
7.89
Tangible book value per share
12.23
5.24
3.2
1.62
7.69
Working capital per share
6.56
5.02
2.76
0.82
5.64
Book value per share
12.23
5.24
3.2
2.05
9.32
Noticias
TD Cowen inicia cobertura de Century Therapeutics con calificación de compra
TD Cowen inicia cobertura de Century Therapeutics con calificación de Compra
TD Cowen initiates Century Therapeutics stock rating at Buy
Clear Street reitera calificación de Compra para Century Therapeutics a $6.60
Clear Street reitera calificación de Compra para acciones de Century Therapeutics a 6,60 dólares
Oracle, Palantir among market cap stock movers on Monday
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler
Clear Street reduce precio objetivo de Century Therapeutics a $6.60
Objetivo de precio de las acciones de Century Therapeutics reducido a 6,60 dólares en Clear Street
Century Therapeutics stock price target lowered to $6.60 at Clear Street
Century Therapeutics obtiene $135 millones en colocación privada